Clinical Trials Logo

Filter by:
NCT ID: NCT05357989 Completed - Clinical trials for Parkinson's Disease, Idiopathic

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Start date: August 3, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to measure safety and efficacy of buntanetap/posiphen capsules compared with placebo capsules in participants with early PD. Study details include: - The study duration will be up to 7-8 months. - The double-blind treatment duration will be up to 6 months. - There will be 5 in-clinic visits and 7 phone calls

NCT ID: NCT05357885 Completed - Clinical trials for Laboratory Assessment SARS-CoV-2 Antibody Levels Before and After Surgery for Patients Requiring Cardiopulmonary Bypass

Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass

Start date: November 17, 2021
Phase:
Study type: Observational

This study is designed to compare the levels of SARS-CoV-2 antibody prior to cardiopulmonary bypass and after cardiopulmonary bypass (CPB).

NCT ID: NCT05357833 Completed - Multiple Sclerosis Clinical Trials

Novel Imaging Markers in SPMS

Start date: June 1, 2022
Phase: Early Phase 1
Study type: Interventional

This pilot study takes the innovative approach of using ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle enhanced MRI to measure activity of the innate immune system within MS lesions. Activity of innate immunity has been hypothesized as one of the critical pathologic processes underpinning neurologic worsening in progressive MS. As such, in the short term this project proposes to investigate USPIO uptake in SPMS lesions as a promising in vivo imaging biomarker for chronic-active lesions, as distinguished from chronic-inactive lesions.

NCT ID: NCT05357755 Completed - Plaque Psoriasis Clinical Trials

A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis

SUMMIT
Start date: June 13, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to evaluate the efficacy of an oral tablet formulation of JNJ-77242113 compared with placebo in participants with moderate-to-severe plaque psoriasis.

NCT ID: NCT05357586 Completed - Depression Clinical Trials

The Pitt Center for Emergency Responder Wellness

Start date: March 29, 2022
Phase: N/A
Study type: Interventional

Emergency responders protect the public despite occupational hazards that threaten their mental health. The Pitt Center for Emergency Responder Wellness will be a clinical innovation hub that: 1) delivers accessible interventions for promoting mental health and overall wellbeing; 2) trains the next generation of students to provide mental health care for emergency responders; and 3) informs scientific understanding of post-trauma recovery processes. Goals for the seed phase are to establish our team and collect pilot data to demonstrate feasibility and initial clinical impact.

NCT ID: NCT05357352 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

Start date: May 24, 2019
Phase:
Study type: Observational

Few studies have evaluated an extensive list of possible risk factors for NAFLD for their association with presence and severity of histologic features. We wish to conduct a retrospective study on these possible factors (including demographics, comorbid diseases, and medications) for their association, if any, with severity of histopathologic findings. This study hypothesize that certain risk factors, specifically those contributing to or consisting of metabolic syndrome, will have higher NASH Fibrosis stages.

NCT ID: NCT05357248 Completed - Clinical trials for Non-Alcoholic Fatty Liver Disease

Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH

Start date: April 10, 2022
Phase: N/A
Study type: Interventional

This single arm interventional cohort study is designed to explore the feasibility of using BT-NCBT-00x to improve liver fat, inflammation, and stiffness in patients diagnosed with NAFLD or NASH over a 3 month intervention.

NCT ID: NCT05356988 Completed - Depression Clinical Trials

Health and Energy Through Active Living Every Day After Cancer Intervention for Cancer Survivors

HEALED
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the Health and Energy through Active Living Every Day (HEALED) intervention, is to examine the effect of a web-based intervention on changes in device-measured physical activity (light and moderate-to-vigorous intensity aerobic) and sedentary behavior. The purpose of this study is intended for survivors of a cancer with a 5-year survival (at Stage I, II, and III) of at least 45% that has a strong level of evidence for association with physical inactivity according to the 2018 PA Guidelines Advisory Committee Report (breast, colon, endometrium, kidney, bladder, multiple myeloma). In line with social cognitive theory behavior change techniques, participants will be provided information and skills necessary to be more physically active and less sedentary after a cancer diagnosis. New materials will be disseminated biweekly through a website open only to participants, and include at-home exercise demonstration videos, research news, discussion boards, success stories, infographics for exercise recommendations, etc.

NCT ID: NCT05356793 Completed - Clinical trials for Acute Infectious Conjunctivitis (Disorder)

The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis

SCH1TAIC
Start date: September 1, 2021
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate the efficacy of Sasch1, a novel anti-infective eyedrop, in the treatment of acute infectious conjunctivitis.

NCT ID: NCT05356754 Completed - Hypertension Clinical Trials

VL-3 Training Study

Start date: July 13, 2020
Phase: N/A
Study type: Interventional

The primary endpoints for this study are mean and standard deviation error measurements for the VLDBPM versus manual auscultation.